PMID- 33845846 OWN - NLM STAT- MEDLINE DCOM- 20211111 LR - 20211111 IS - 1476-511X (Electronic) IS - 1476-511X (Linking) VI - 20 IP - 1 DP - 2021 Apr 12 TI - Gender differences in risk factors for high plasma homocysteine levels based on a retrospective checkup cohort using a generalized estimating equation analysis. PG - 31 LID - 10.1186/s12944-021-01459-z [doi] LID - 31 AB - BACKGROUND: Hyperhomocysteinemia (HHcy) is associated with various health problems, but less is known about the gender differences in risk factors for high plasma homocysteine (Hcy) levels. METHODS: In this study, a retrospective study was carried out on 14,911 participants (7838 males and 7073 females) aged 16-102 years who underwent routine checkups between January 2012 and December 2017 in the Health Management Department of Xuanwu Hospital, China. Anthropometric measurements, including body mass index (BMI) and waist-to-hip ratio, were collected. Fasting blood samples were collected to measure the biochemical indexes. The outcome variable was Hcy level, and a generalized estimating equation (GEE) analysis was used to identify the associations of interest based on gender. RESULTS: Males exhibited increased Hcy levels (16.37 +/- 9.66 vs 11.22 +/- 4.76 mumol/L) and prevalence of HHcy (37.0% vs 11.3%) compared with females. Hcy levels and HHcy prevalence increased with age in both genders, except for the 16- to 29-year-old group. GEE analysis indicated that irrespective of gender, aspartate aminotransferase, creatinine, uric acid, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol levels were positively correlated with Hcy levels, and alanine aminotransferase, total cholesterol and glucose were negatively correlated with Hcy levels. However, age, BMI and triglycerides (TGs) were positively correlated with Hcy levels exclusively in females. CONCLUSIONS: Gender differences in risk factors for high plasma Hcy levels were noted. Although common correlational factors existed in both genders, age, BMI and TGs were independent risk factors for Hcy levels specifically in females. FAU - Zhao, Jing AU - Zhao J AD - Health Management Department, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China. FAU - Li, Zhihua AU - Li Z AD - Information Center, Xuanwu Hospital, Capital Medical University, Beijing, China. FAU - Hou, Chengbei AU - Hou C AD - Department of Evidence-based Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China. FAU - Sun, Fei AU - Sun F AD - Beijing Geriatric Healthcare Center, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China. FAU - Dong, Jing AU - Dong J AD - Health Management Department, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China. FAU - Chu, Xi AU - Chu X AD - Health Management Department, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China. cissy9007@163.com. FAU - Guo, Yansu AU - Guo Y AUID- ORCID: 0000-0002-4367-5353 AD - Beijing Geriatric Healthcare Center, Xuanwu Hospital, Capital Medical University, No. 45 Changchun Street, Xicheng District, Beijing, 100053, China. gys188@163.com. LA - eng GR - 81971200/National Natural Science Foundation of China/ PT - Journal Article DEP - 20210412 PL - England TA - Lipids Health Dis JT - Lipids in health and disease JID - 101147696 RN - 0LVT1QZ0BA (Homocysteine) SB - IM MH - Adolescent MH - Adult MH - Age Distribution MH - Aged MH - Aged, 80 and over MH - China/epidemiology MH - Factor Analysis, Statistical MH - Female MH - Homocysteine/*blood MH - Humans MH - Hyperhomocysteinemia/blood/epidemiology MH - Male MH - Middle Aged MH - *Models, Biological MH - Prevalence MH - Retrospective Studies MH - Risk Factors MH - *Sex Characteristics MH - Young Adult PMC - PMC8042914 OTO - NOTNLM OT - Aging OT - Body mass index OT - Gender difference OT - Homocysteine OT - Hyperhomocysteinemia OT - Risk factor OT - Triglycerides COIS- The authors declare that they have no competing interests. EDAT- 2021/04/14 06:00 MHDA- 2021/11/12 06:00 PMCR- 2021/04/12 CRDT- 2021/04/13 05:35 PHST- 2021/02/14 00:00 [received] PHST- 2021/03/30 00:00 [accepted] PHST- 2021/04/13 05:35 [entrez] PHST- 2021/04/14 06:00 [pubmed] PHST- 2021/11/12 06:00 [medline] PHST- 2021/04/12 00:00 [pmc-release] AID - 10.1186/s12944-021-01459-z [pii] AID - 1459 [pii] AID - 10.1186/s12944-021-01459-z [doi] PST - epublish SO - Lipids Health Dis. 2021 Apr 12;20(1):31. doi: 10.1186/s12944-021-01459-z.